COO of Denali
Alexander Schuth is one of our co-founders and serves as our Chief Operating Officer and Head of Corporate Development. Alex was previously Director and Head Technology and Diagnostics Partnering and, before that, Head of Neuroscience Partnering at Genentech. During his 10-year tenure at Genentech, he held various operational and leadership positions, gaining significant drug development experience and contributing to the growth and success of Genentech’s pipeline. Before joining Genentech, Alex worked for several years in Merrill Lynch’s investment banking group, where his responsibilities included executing IPOs and other equity capital market transactions. Alex holds an M.B.A. from the Wharton School of the University of Pennsylvania and an M.D. from the Charite Medical School at the Humboldt University in Berlin, Germany.